210 related articles for article (PubMed ID: 21750651)
1. Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.
Ray D; Ahsan A; Helman A; Chen G; Hegde A; Gurjar SR; Zhao L; Kiyokawa H; Beer DG; Lawrence TS; Nyati MK
Neoplasia; 2011 Jul; 13(7):570-8. PubMed ID: 21750651
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
David D; Surendran A; Thulaseedharan JV; Nair AS
BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
[TBL] [Abstract][Full Text] [Related]
4. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
[TBL] [Abstract][Full Text] [Related]
5. KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation.
Shukla S; Allam US; Ahsan A; Chen G; Krishnamurthy PM; Marsh K; Rumschlag M; Shankar S; Whitehead C; Schipper M; Basrur V; Southworth DR; Chinnaiyan AM; Rehemtulla A; Beer DG; Lawrence TS; Nyati MK; Ray D
Neoplasia; 2014 Feb; 16(2):115-28. PubMed ID: 24709419
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation.
Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE
Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501
[TBL] [Abstract][Full Text] [Related]
7. MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitination.
Chae DK; Park J; Cho M; Ban E; Jang M; Yoo YS; Kim EE; Baik JH; Song EJ
Mol Oncol; 2019 Dec; 13(12):2663-2678. PubMed ID: 31581360
[TBL] [Abstract][Full Text] [Related]
8. Non-thermal plasma induces AKT degradation through turn-on the MUL1 E3 ligase in head and neck cancer.
Kim SY; Kim HJ; Kang SU; Kim YE; Park JK; Shin YS; Kim YS; Lee K; Kim CH
Oncotarget; 2015 Oct; 6(32):33382-96. PubMed ID: 26450902
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.
Kim DG; Lee JY; Lee JH; Cho HY; Kang BS; Jang SY; Kim MH; Guo M; Han JM; Kim SJ; Kim S
Cancer Res; 2016 Jun; 76(11):3422-36. PubMed ID: 27197155
[TBL] [Abstract][Full Text] [Related]
10. Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.
Zhao XC; Wang GZ; Wen ZS; Zhou YC; Hu Q; Zhang B; Qu LW; Gao SH; Liu J; Ma L; Zhang YF; Zhang C; Yu H; Zhang DL; Wang M; Wang CL; Huang YC; Liu ZH; Zhao Y; Chen L; Zhou GB
EBioMedicine; 2020 Mar; 53():102689. PubMed ID: 32114396
[TBL] [Abstract][Full Text] [Related]
11. SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation.
Han M; Guo Y; Li Y; Zeng Q; Zhu W; Jiang J
Int J Biol Sci; 2023; 19(11):3324-3340. PubMed ID: 37497010
[TBL] [Abstract][Full Text] [Related]
12. Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
Lin YC; Wu MH; Wei TT; Chuang SH; Chen KF; Cheng AL; Chen CC
Neoplasia; 2012 Jun; 14(6):463-75. PubMed ID: 22787428
[TBL] [Abstract][Full Text] [Related]
13. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.
Liu X; Gu X; Sun L; Flowers AB; Rademaker AW; Zhou Y; Kiyokawa H
BMC Cancer; 2014 Feb; 14():57. PubMed ID: 24485087
[TBL] [Abstract][Full Text] [Related]
15. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.
Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI
Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570
[TBL] [Abstract][Full Text] [Related]
16. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain.
Wiesner S; Ogunjimi AA; Wang HR; Rotin D; Sicheri F; Wrana JL; Forman-Kay JD
Cell; 2007 Aug; 130(4):651-62. PubMed ID: 17719543
[TBL] [Abstract][Full Text] [Related]
17. Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth.
Ahmed AU; Schmidt RL; Park CH; Reed NR; Hesse SE; Thomas CF; Molina JR; Deschamps C; Yang P; Aubry MC; Tang AH
J Natl Cancer Inst; 2008 Nov; 100(22):1606-29. PubMed ID: 19001609
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation.
Hsu HY; Lin TY; Wu YC; Tsao SM; Hwang PA; Shih YW; Hsu J
Oncotarget; 2014 Sep; 5(17):7870-85. PubMed ID: 25149540
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY; Kao YR; Lee TC; Wu CW
Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
[TBL] [Abstract][Full Text] [Related]
20. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.
Dong S; Liu J; Li L; Wang H; Ma H; Zhao Y; Zhao J
Am J Physiol Cell Physiol; 2019 May; 316(5):C632-C640. PubMed ID: 30758996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
